Granulomatous pneumonitis, sclerosing cholangitis, and pancreatitis in a child with Crohn disease: Response to infliximab

Journal of Pediatric Gastroenterology and Nutrition

Volumn 42, Issue 3, 2006, Pages 324-326

  Silbermintz, Ari ^a   Krishnan, Sankaran ^b   Banquet, Agnes ^b   Markowitz, James ^a  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; URSODEOXYCHOLIC ACID;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTICLE; BACKACHE; CASE REPORT; COLONOSCOPY; COUGHING; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; DUODENITIS; DUODENUM BIOPSY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; GRANULOMA; HUMAN; IMMUNOMODULATION; LUNG GRANULOMA; NAUSEA; PANCREATITIS; PARENTERAL NUTRITION; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROSING CHOLANGITIS; TIME SERIES ANALYSIS; TRIACYLGLYCEROL LIPASE BLOOD LEVEL;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CHOLANGITIS, SCLEROSING; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; PANCREATITIS; PNEUMONIA; TREATMENT OUTCOME;

EID: 33645321124     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000189347.32796.c5     Document Type: Article

References (13)

1. Casey M, Tazelaar H, Myers L, et al. Noninfectious lung pathology with Crohn's disease. Am J Surg Pathol 2003;27: 213-9.
2. Calder CJ, Lacy D, Raafat F, et al. Crohn's disease with pulmonary involvement in a 3 year old boy. Gut 1993;34:1636-8.
3. Foster RA, Zander DS, Mergo PJ, et al. Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations. Inflamm Bowel Dis 2003;9:308-15.
4. Camus P, Piard F, Ashcroft T, et al. The lung in inflammatory bowel disease. Medicine 1993;72:151-83.
5. Regueiro M, Valentine J, Plevy S, et al. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98:1821-6.
6. Joseph A, Raj D, Dua HS, et al. Infliximab in the treatment of refractory posterior uveitis. Ophthalmology 2003;110:1449-53.
7. El-Shabrawi Y, Hermann J. Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology 2002;109:2342-6.
8. Van den Bosch F, Kruithof E, Baeten D, et al. Crohn's disease associated with spondyloarthropathy: effect of TNF-alpha blockade with infliximab on articular symptoms. Lancet 2000;356:1821-2.
9. Van den Bosch F, Kruithof E, Baeten D, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondyloarthropathy. Arthritis Rheum 2002;46:755-6.
10. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab: a randomized controlled multicenter trial. Lancet 2002;359:1187-93.
11. Alrashid AI, Brown RD, Mihalov ML, et al. Crohn's disease involving the lung; resolution with infliximab. Dig Dis Sci 2001;46:1736-9.
12. Regueiro M, Chopra K, Slivks A. Abstract no. 106288. Dig Dis Week 2003;5.
13. Smith MA, Kozarek RA. Does Infliximab improve liver function tests in patients with primary sclerosing cholangitis? Am J Gastroenterol 2002;97:S71.